Page last updated: 2024-08-25

sofosbuvir and B16 Melanoma

sofosbuvir has been researched along with B16 Melanoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beeharry, N; Bellacosa, A; Bhattacharjee, V; Cosentino, L; Davidson, G; Davidson, I; Devarajan, K; Dorjsuren, DG; Einarson, M; Giordano, A; Jelinek, J; Kadariya, Y; Katz, RA; Larue, L; Mancuso, P; Nicolas, E; Simeonov, A; Sobol, RW; Sun, H; Testa, JR; Tricarico, R; Yen, TJ	1

Other Studies

1 other study(ies) available for sofosbuvir and B16 Melanoma

Article	Year
Thymine DNA glycosylase as a novel target for melanoma. Oncogene, 2019, Volume: 38, Issue:19 Topics: Animals; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cytosine; DNA Methylation; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Humans; Melanoma; Melanoma, Experimental; Mice, Knockout; Mice, SCID; Mice, Transgenic; Molecular Targeted Therapy; Thymine DNA Glycosylase; Xenograft Model Antitumor Assays	2019

Article

Year

Thymine DNA glycosylase as a novel target for melanoma.

Oncogene, 2019, Volume: 38, Issue:19

Topics: Animals; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cytosine; DNA Methylation; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Humans; Melanoma; Melanoma, Experimental; Mice, Knockout; Mice, SCID; Mice, Transgenic; Molecular Targeted Therapy; Thymine DNA Glycosylase; Xenograft Model Antitumor Assays

2019